M
0.325
0.00 (0.84%)
| 前收盘价格 | 0.322 |
| 收盘价格 | 0.322 |
| 成交量 | 859,696 |
| 平均成交量 (3个月) | 2,510,210 |
| 市值 | 17,935,320 |
| 价格/销量 (P/S) | 0.970 |
| 股市价格/股市净资产 (P/B) | 3.17 |
| 52周波幅 | |
| 利润日期 | 12 Nov 2024 |
| 营业利益率 (TTM) | -375.94% |
| 稀释每股收益 (EPS TTM) | -2.47 |
| 季度收入增长率 (YOY) | 32.50% |
| 流动比率 (MRQ) | 2.28 |
| 营业现金流 (OCF TTM) | -120.47 M |
| 杠杆自由现金流 (LFCF TTM) | -66.13 M |
| 资产报酬率 (ROA TTM) | -57.75% |
| 股东权益报酬率 (ROE TTM) | -2,986.55% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Marinus Pharmaceuticals, Inc. | 看跌 | - |
AIStockmoo 评分
0.3
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.25 |
|
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 10.94% |
| 机构持股比例 | 83.04% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 4.00 (Cantor Fitzgerald, 1,130.77%) | 购买 |
| 中 | 2.50 (669.23%) | |
| 低 | 0.500 (Jefferies, 53.85%) | 保留 |
| 平均值 | 2.25 (592.31%) | |
| 总计 | 3 购买, 3 保留 | |
| 平均价格@调整类型 | 0.338 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Cantor Fitzgerald | 14 Nov 2024 | 4.00 (1,130.77%) | 购买 | 0.309 |
| 25 Oct 2024 | 4.00 (1,130.77%) | 购买 | 0.405 | |
| HC Wainwright & Co. | 14 Nov 2024 | 2.00 (515.38%) | 保留 | 0.309 |
| D. Boral Capital | 13 Nov 2024 | 3.00 (823.08%) | 购买 | 0.302 |
| Jefferies | 25 Oct 2024 | 0.500 (53.85%) | 保留 | 0.405 |
| RBC Capital | 25 Oct 2024 | 1.00 (207.69%) | 保留 | 0.405 |
| EF Hutton | 24 Oct 2024 | 3.00 (823.08%) | 购买 | 0.296 |
| 17 Oct 2024 | 23.00 (6,976.92%) | 购买 | 1.74 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合